Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940967

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940967

Genetic Toxicology Testing Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The global Genetic Toxicology Testing Market is experiencing strong and sustained growth as regulatory bodies and industries intensify their focus on product safety and genetic risk assessment. Genetic toxicology testing is essential for evaluating the potential of substances to cause genetic mutations, chromosomal damage, or DNA alterations. These tests form a critical component of safety evaluations across pharmaceuticals, biotechnology, food, cosmetics, agriculture, and chemical industries.

The market is expected to reach USD 1.8 billion in 2026 and expand significantly to USD 3.6 billion by 2033, progressing at a compound annual growth rate (CAGR) of 10.20% during the forecast period. The growth outlook reflects increasing global research activity, technological innovation, and stricter compliance requirements across industries.

Market Insights

Genetic toxicology testing encompasses a broad range of assays conducted both in vitro and in vivo to detect genotoxic effects early in product development. These assessments help organizations identify harmful compounds before commercialization, minimizing regulatory risks and protecting public health.

The pharmaceutical and biotechnology industries remain the primary contributors to market growth. The increasing development of complex therapies, including biologics and advanced molecular treatments, has heightened the need for comprehensive genetic safety profiling. In addition, contract research organizations are expanding their service offerings to meet rising demand for outsourced toxicology testing.

The steady increase from USD 1.8 billion in 2026 to USD 3.6 billion in 2033 highlights the growing reliance on advanced laboratory technologies, automation, and high-throughput screening systems. These innovations enhance efficiency, improve reproducibility, and reduce testing timelines.

Market Drivers

One of the strongest drivers of the Genetic Toxicology Testing Market is the implementation of stringent regulatory guidelines worldwide. Health authorities require detailed genotoxicity data before approving drugs, chemicals, and consumer products. This regulatory emphasis compels manufacturers to conduct thorough testing and maintain high safety standards.

The rapid expansion of drug discovery and development pipelines also supports market growth. With increasing global investment in research and development, particularly for chronic and rare diseases, companies must conduct extensive safety assessments at every stage of development.

Technological advancements further accelerate market expansion. Automated platforms, improved assay sensitivity, and integration of genomic technologies have enhanced the precision and reliability of genetic toxicology testing. Growing awareness of environmental and occupational exposure risks is also broadening the application of genotoxicity assessments across industrial sectors.

Business Opportunities

The market offers significant growth opportunities for service providers and technology developers. Outsourcing trends continue to strengthen, as pharmaceutical and biotechnology firms rely on specialized laboratories to manage complex toxicology studies. This creates consistent demand for testing services and integrated solutions.

Emerging markets present promising opportunities due to expanding healthcare infrastructure and increasing pharmaceutical manufacturing activities. Establishing regional testing facilities and forming strategic partnerships can help companies capture untapped potential in these regions.

Additionally, the growing shift toward alternative testing approaches that reduce animal usage presents opportunities for innovation. Development of advanced cell-based assays and predictive in vitro models aligns with evolving ethical standards and regulatory expectations.

Region Analysis

North America holds a leading position in the Genetic Toxicology Testing Market, supported by strong research infrastructure, advanced regulatory systems, and the presence of major pharmaceutical and biotechnology companies. Continuous investment in research and development strengthens the region's market share.

Europe remains a key contributor due to its rigorous safety regulations and strong focus on environmental and consumer protection. The region's well-established laboratory networks and research collaborations drive consistent growth.

Asia Pacific is anticipated to register the fastest growth during the forecast period. Rapid industrial development, increasing pharmaceutical production, and rising government support for biotechnology research are major factors driving expansion in countries such as China, India, and Japan.

Latin America and the Middle East & Africa are gradually emerging as growth regions. Improvements in regulatory frameworks and healthcare infrastructure are encouraging broader adoption of standardized genetic toxicology testing procedures.

Key Players

  • Thermo Fisher Scientific
  • PerkinElmer, Inc.
  • Agilent Technologies
  • Shimadzu Corporation
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Illumina, Inc.
  • Qiagen N.V.
  • Charles River Laboratories
  • Eurofins Scientific
  • SGS SA
  • Toxikon (Extended Validation Services)
  • WuXi AppTec
  • Laboratory Corporation of America (LabCorp)
  • Covance

These companies focus on innovation, strategic collaborations, and geographic expansion to strengthen their competitive positions and broaden their service portfolios.

Market Segmentation

By Product

  • Reagents & Consumables
  • Assays
  • Services

By Application

  • Healthcare Industry (Pharmaceutical & Biotechnology)
  • Food Industry
  • Cosmetics Industry
  • Other Industries (Agriculture and Chemical)

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Genetic Toxicology Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Genetic Toxicology Testing Market Outlook, 2020-2033

  • 3.1. Global Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Reagents & Consumables
    • 3.1.2. Assays
    • 3.1.3. Services
  • 3.2. Global Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.2.1. Healthcare Industry (Pharmaceutical & Biotechnology)
    • 3.2.2. Food Industry
    • 3.2.3. Cosmetics Industry
    • 3.2.4. Other Industries (Agriculture and Chemical)
  • 3.3. Global Genetic Toxicology Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.3.1. North America
    • 3.3.2. Europe
    • 3.3.3. Asia Pacific
    • 3.3.4. Latin America
    • 3.3.5. Middle East & Africa

4. North America Genetic Toxicology Testing Market Outlook, 2020-2033

  • 4.1. North America Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Reagents & Consumables
    • 4.1.2. Assays
    • 4.1.3. Services
  • 4.2. North America Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.2.1. Healthcare Industry (Pharmaceutical & Biotechnology)
    • 4.2.2. Food Industry
    • 4.2.3. Cosmetics Industry
    • 4.2.4. Other Industries (Agriculture and Chemical)
  • 4.3. North America Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.3.1. U.S. Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 4.3.2. U.S. Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 4.3.3. Canada Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 4.3.4. Canada Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
  • 4.4. BPS Analysis/Market Attractiveness Analysis

5. Europe Genetic Toxicology Testing Market Outlook, 2020-2033

  • 5.1. Europe Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Reagents & Consumables
    • 5.1.2. Assays
    • 5.1.3. Services
  • 5.2. Europe Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.2.1. Healthcare Industry (Pharmaceutical & Biotechnology)
    • 5.2.2. Food Industry
    • 5.2.3. Cosmetics Industry
    • 5.2.4. Other Industries (Agriculture and Chemical)
  • 5.3. Europe Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.3.1. Germany Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 5.3.2. Germany Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 5.3.3. Italy Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 5.3.4. Italy Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 5.3.5. France Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 5.3.6. France Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 5.3.7. U.K. Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 5.3.8. U.K. Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 5.3.9. Spain Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 5.3.10. Spain Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 5.3.11. Russia Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 5.3.12. Russia Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 5.3.13. Rest of Europe Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 5.3.14. Rest of Europe Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
  • 5.4. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Genetic Toxicology Testing Market Outlook, 2020-2033

  • 6.1. Asia Pacific Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Reagents & Consumables
    • 6.1.2. Assays
    • 6.1.3. Services
  • 6.2. Asia Pacific Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.2.1. Healthcare Industry (Pharmaceutical & Biotechnology)
    • 6.2.2. Food Industry
    • 6.2.3. Cosmetics Industry
    • 6.2.4. Other Industries (Agriculture and Chemical)
  • 6.3. Asia Pacific Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.3.1. China Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 6.3.2. China Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 6.3.3. Japan Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 6.3.4. Japan Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 6.3.5. South Korea Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 6.3.6. South Korea Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 6.3.7. India Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 6.3.8. India Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 6.3.9. Southeast Asia Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 6.3.10. Southeast Asia Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 6.3.11. Rest of SAO Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 6.3.12. Rest of SAO Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
  • 6.4. BPS Analysis/Market Attractiveness Analysis

7. Latin America Genetic Toxicology Testing Market Outlook, 2020-2033

  • 7.1. Latin America Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Reagents & Consumables
    • 7.1.2. Assays
    • 7.1.3. Services
  • 7.2. Latin America Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.2.1. Healthcare Industry (Pharmaceutical & Biotechnology)
    • 7.2.2. Food Industry
    • 7.2.3. Cosmetics Industry
    • 7.2.4. Other Industries (Agriculture and Chemical)
  • 7.3. Latin America Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.3.1. Brazil Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 7.3.2. Brazil Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 7.3.3. Mexico Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 7.3.4. Mexico Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 7.3.5. Argentina Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 7.3.6. Argentina Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 7.3.7. Rest of LATAM Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 7.3.8. Rest of LATAM Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
  • 7.4. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Genetic Toxicology Testing Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Reagents & Consumables
    • 8.1.2. Assays
    • 8.1.3. Services
  • 8.2. Middle East & Africa Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.2.1. Healthcare Industry (Pharmaceutical & Biotechnology)
    • 8.2.2. Food Industry
    • 8.2.3. Cosmetics Industry
    • 8.2.4. Other Industries (Agriculture and Chemical)
  • 8.3. Middle East & Africa Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.3.1. GCC Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 8.3.2. GCC Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 8.3.3. South Africa Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 8.3.4. South Africa Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 8.3.5. Egypt Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 8.3.6. Egypt Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 8.3.7. Nigeria Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 8.3.8. Nigeria Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
    • 8.3.9. Rest of Middle East Genetic Toxicology Testing Market Outlook, by Product, 2020-2033
    • 8.3.10. Rest of Middle East Genetic Toxicology Testing Market Outlook, by Application, 2020-2033
  • 8.4. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. PerkinElmer, Inc.
    • 9.4.3. Agilent Technologies
    • 9.4.4. Shimadzu Corporation
    • 9.4.5. Bio-Rad Laboratories
    • 9.4.6. Danaher Corporation
    • 9.4.7. Illumina, Inc.
    • 9.4.8. Qiagen N.V.
    • 9.4.9. Charles River Laboratories
    • 9.4.10. Eurofins Scientific

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!